222 related articles for article (PubMed ID: 24986265)
1. Optimizing pharmacotherapy of systemic lupus erythematosus: the pharmacist role.
Al Hussaini M; Hammouda EI; Hammouda AE
Int J Clin Pharm; 2014 Aug; 36(4):684-92. PubMed ID: 24986265
[TBL] [Abstract][Full Text] [Related]
2. Systemic lupus erythematosus: a review of the disease and treatment options.
Gurevitz SL; Snyder JA; Wessel EK; Frey J; Williamson BA
Consult Pharm; 2013 Feb; 28(2):110-21. PubMed ID: 23395811
[TBL] [Abstract][Full Text] [Related]
3. Late-onset systemic lupus erythematosus: epidemiology, diagnosis and treatment.
Arnaud L; Mathian A; Boddaert J; Amoura Z
Drugs Aging; 2012 Mar; 29(3):181-189. PubMed ID: 22263748
[TBL] [Abstract][Full Text] [Related]
4. Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus.
James JA; Kim-Howard XR; Bruner BF; Jonsson MK; McClain MT; Arbuckle MR; Walker C; Dennis GJ; Merrill JT; Harley JB
Lupus; 2007; 16(6):401-9. PubMed ID: 17664230
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and prognosis of late-onset systemic lupus erythematosus: results from the 1000 faces of lupus study.
Lalani S; Pope J; de Leon F; Peschken C;
J Rheumatol; 2010 Jan; 37(1):38-44. PubMed ID: 20008925
[TBL] [Abstract][Full Text] [Related]
6. Interventions for cutaneous disease in systemic lupus erythematosus.
Hannon CW; McCourt C; Lima HC; Chen S; Bennett C
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD007478. PubMed ID: 33687069
[TBL] [Abstract][Full Text] [Related]
7. Systemic lupus erythematosus. How to manage, when to refer.
Dall'Era M; Davis JC
Postgrad Med; 2003 Nov; 114(5):31-7, 40. PubMed ID: 14650091
[TBL] [Abstract][Full Text] [Related]
8. The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature.
Jallouli M; Saadoun D; Eymard B; Leroux G; Haroche J; Le Thi Huong D; De Gennes C; Chapelon C; Benveniste O; Wechsler B; Cacoub P; Amoura Z; Piette JC; Costedoat-Chalumeau N
J Neurol; 2012 Jul; 259(7):1290-7. PubMed ID: 22160434
[TBL] [Abstract][Full Text] [Related]
9. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
Ampélas JF; Wattiaux MJ; Van Amerongen AP
Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
[TBL] [Abstract][Full Text] [Related]
10. Early Lupus Project - A multicentre Italian study on systemic lupus erythematosus of recent onset.
Sebastiani GD; Prevete I; Piga M; Iuliano A; Bettio S; Bortoluzzi A; Coladonato L; Tani C; Spinelli FR; Fineschi I; Mathieu A
Lupus; 2015 Oct; 24(12):1276-82. PubMed ID: 25979916
[TBL] [Abstract][Full Text] [Related]
11. Systemic Lupus Erythematosus: Diagnosis and Treatment.
Lam NV; Brown JA; Sharma R
Am Fam Physician; 2023 Apr; 107(4):383-395. PubMed ID: 37054414
[TBL] [Abstract][Full Text] [Related]
12. Systemic lupus erythematosus: an overview.
Askanase A; Shum K; Mitnick H
Soc Work Health Care; 2012; 51(7):576-86. PubMed ID: 22905974
[TBL] [Abstract][Full Text] [Related]
13. Systemic lupus erythematosus: safe and effective management in primary care.
Michalski JP; Kodner C
Prim Care; 2010 Dec; 37(4):767-78, vii. PubMed ID: 21050957
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus.
Groot N; Shaikhani D; Teng YKO; de Leeuw K; Bijl M; Dolhain RJEM; Zirkzee E; Fritsch-Stork R; Bultink IEM; Kamphuis S
Arthritis Rheumatol; 2019 Feb; 71(2):290-301. PubMed ID: 30152151
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus.
Vázquez-Otero I; Medina-Cintrón N; Arroyo-Ávila M; González-Sepúlveda L; Vilá LM
Lupus Sci Med; 2020 May; 7(1):. PubMed ID: 32434863
[TBL] [Abstract][Full Text] [Related]
16. Systemic lupus erythematosus: epidemiology, pathophysiology, manifestations, and management.
Fortuna G; Brennan MT
Dent Clin North Am; 2013 Oct; 57(4):631-55. PubMed ID: 24034070
[TBL] [Abstract][Full Text] [Related]
17. Mortality and disease related comorbidities in systemic lupus erythematosus: Data from an Egyptian cohort.
A Mohammed RH; Lotfy Fayed H; Ibrahim Emara N
Lupus; 2022 Apr; 31(5):628-636. PubMed ID: 35306918
[TBL] [Abstract][Full Text] [Related]
18. Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE): study protocol for a randomized controlled trial.
Olsen NJ; James JA; Arriens C; Ishimori ML; Wallace DJ; Kamen DL; Chong BF; Liao D; Chinchilli VM; Karp DR
Trials; 2018 Dec; 19(1):694. PubMed ID: 30572906
[TBL] [Abstract][Full Text] [Related]
19. Systemic lupus erythematosus: review of synthetic drugs.
Tsang-A-Sjoe MW; Bultink IE
Expert Opin Pharmacother; 2015; 16(18):2793-806. PubMed ID: 26479437
[TBL] [Abstract][Full Text] [Related]
20. [Systemic lupus erythematosus in children and adolescents].
Sallmann S; Fiebig B; Hedrich CM; Heubner G; Gahr M
Z Rheumatol; 2006 Nov; 65(7):576-8, 580-2, 584-5. PubMed ID: 17072573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
